ISRG,CAMP Stock Price and Quote

Jul 18, 4:03 AMIntuitive Q2 revenue $2.89B up 19%, non-GAAP EPS up 28% as it raises 2026 gross margin guidance

Peers: MDT SYK ABT BSX EW BDX ZBH BAX TFX MDLN

| Held by: VTI VOO QQQ IVV SPY VUG XLV QQQM IWF VHT

Index	NDX, S&P 500
Market Cap	122.97B
Enterprise Value	114.47B
Income	3.14B
Sales	11.03B
Book/sh	49.31
Cash/sh	24.35
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	17021
IPO	Jun 13, 2000

P/E	39.79
Forward P/E	28.81
PEG	1.91
P/S	11.14
P/B	7.04
P/C	14.26
P/FCF	43.39
EV/EBITDA	29.38
EV/Sales	10.37
Quick Ratio	3.59
Current Ratio	4.61
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	8.73
EPS next Y	12.05
EPS next Q	2.63
EPS this Y	20.14%
EPS next Y	12.35%
EPS next 5Y	15.05%
EPS past 3/5Y	29.18% 21.79%
Sales past 3/5Y	17.39% 18.22%
EPS Y/Y TTM	21.06%
Sales Y/Y TTM	20.66%
EPS Q/Q	26.64%
Sales Q/Q	18.54%
Earnings	Jul 16 AMC
EPS/Sales Surpr.	11.50% 2.37%

Insider Own	0.67%
Insider Trans	-2.00%
Inst Own	86.60%
Inst Trans	-0.16%
ROA	15.30%
ROE	17.37%
ROIC	17.96%
Gross Margin	71.58%
Oper. Margin	31.28%
Profit Margin	28.45%
SMA20	-13.29%
SMA50	-16.31%
SMA200	-28.57%
Trades

Shs Outstand	354.16M
Shs Float	351.78M
Short Float	2.08%
Short Ratio	2.66
Short Interest	7.32M
52W High	603.88 -42.50%
52W Low	344.55 0.77%
Volatility	4.14% 3.34%
ATR (14)	16.12
RSI (14)	30.97
Beta	1.47
Rel Volume	0.15
Avg Volume	2.75M
Volume	20,646

Perf Week	-14.72%
Perf Month	-13.67%
Perf Quarter	-26.00%
Perf Half Y	-35.86%
Perf YTD	-38.69%
Perf Year	-33.05%
Perf 3Y	-0.13%
Perf 5Y	9.07%
Perf 10Y	344.48%
Recom	1.83
Target Price	508.00
Prev Close	345.42
Price	347.21
Change	0.52%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-09-26	Initiated	BMO Capital Markets	Outperform	$518
Mar-11-26	Upgrade	Citigroup	Neutral → Buy	$590
Jan-27-26	Initiated	TD Cowen	Buy	$660
Dec-11-25	Downgrade	Citigroup	Buy → Neutral	$635
Jul-23-25	Downgrade	Erste Group	Buy → Hold
Jun-09-25	Downgrade	Deutsche Bank	Hold → Sell	$440
Jun-05-25	Upgrade	Erste Group	Hold → Buy
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$522 → $650
Aug-02-24	Upgrade	Redburn Atlantic	Neutral → Buy	$380 → $510
Jul-10-24	Reiterated	Citigroup	Buy	$462 → $512
May-30-24	Initiated	Goldman	Buy	$500
Nov-17-23	Initiated	HSBC Securities	Buy	$318
Jul-19-23	Initiated	Robert W. Baird	Outperform	$377
Apr-19-23	Reiterated	Wells Fargo	Overweight	$289 → $310
Apr-19-23	Reiterated	Truist	Buy	$300 → $325
Apr-19-23	Reiterated	Stifel	Buy	$285 → $315
Apr-19-23	Reiterated	RBC Capital Mkts	Outperform	$305 → $309
Apr-19-23	Reiterated	Raymond James	Outperform	$270 → $323
Apr-19-23	Reiterated	Morgan Stanley	Equal-Weight	$265 → $285
Apr-19-23	Reiterated	JP Morgan	Overweight	$250 → $335

Show Previous Ratings

Jul-18-26 09:02AM	ROBO's Dip History Offers A Cautious Green Light (Trefis)
Jul-17-26 04:30PM	Intuitive Surgical Inc. stock underperforms Friday when compared to competitors (MarketWatch) -14.15%
04:15PM	Why Intuitive Surgical Stock Plunged Today (Investopedia)
04:00PM	Intuitive Surgical Falls to a 52-Week Low After Beat (GuruFocus.com)
12:52PM	Why Intuitive Surgical Stock Is Tanking Today (GuruFocus.com)
10:38AM	Loading…
10:38AM	Intuitive Surgical shares fall as procedure growth slows despite Q2 earnings beat (Proactive)
09:47AM	ISRG Stock Gets A Barrage Of Price Target Cuts From Wall Street Citi Removes It From Upside 90-Day Catalyst Watch (Stocktwits)
08:34AM	Netflix, Intuitive Surgical tumble premarket (Investing.com)
07:53AM	Why This Surgical Robot Stock Is Still a Buy During Its Worst Day in 4 Years (Barrons.com)
06:13AM	Intuitive Surgical shares slide despite earnings beat as 2026 outlook underwhelms (InvestorsHub)
06:13AM	Intuitive Surgical shares slide despite earnings beat as 2026 outlook underwhelms (ECO) (InvestorsHub)
Jul-16-26 04:05PM	Intuitive Announces Second Quarter Earnings (GlobeNewswire)
09:59AM	Why Abbott Stock Is Reimagining Its Future (Trefis)
05:03AM	Netflix earnings on tap after rough period for the streaming company's stock (MarketWatch)
Jul-15-26 02:33PM	The Open Questions On ISRG Stock (Trefis)
04:30PM	Loading…
Jul-14-26 04:30PM	Intuitive Surgical Inc. stock underperforms Tuesday when compared to competitors (MarketWatch) -6.78%
02:06PM	The Paid-To-Hold Play On ISRG Stock: A 12% Income (Trefis)
08:52AM	ISRG Stock: What Does Its Valuation Imply? (Trefis)
Jul-10-26 07:04AM	Medicaroid wins Europes CE mark for Hinotori surgical robot (MedTech Dive)
Jul-09-26 09:29AM	Just How Much Risk Is Built Into ISRG Stock? (Trefis)
Jul-08-26 12:41PM	Just How Wide Is The Path Ahead For Intuitive Surgical Stock? (Trefis)
Jul-07-26 09:22AM	How To Target A 10% Yield While Catching The BSX Stock Knife? (Trefis)
Jul-06-26 11:31AM	Intuitive Surgical Stock Looks Weighed Down. Its After-Hours Growth Says Otherwise. (Trefis)
Jun-23-26 02:11PM	The Cash-Flow Fortress The Stryker Stock Bears Keep Missing (Trefis)
Jun-18-26 07:01AM	This Undervalued Medical-Devices Stock Is Poised for a Rebound (Barrons.com)
Jun-04-26 06:00AM	Medtronic seeks clearance for Hugo surgical robot in more indications (MedTech Dive)
May-28-26 04:30PM	Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton (GlobeNewswire)
08:03AM	BSX Stock: Don't Try To Catch The Falling Knife (Trefis)
May-21-26 09:15AM	Intuitive Announces Innovations to Advance Quintuple Aim (GlobeNewswire)
May-19-26 11:52AM	Is BSX Stock A Value Trap Or A Rebound Play? (Trefis)
04:30PM	Loading…
May-11-26 04:30PM	Intuitive Surgical Inc. stock underperforms Monday when compared to competitors (MarketWatch) -6.67%
Apr-24-26 07:00AM	J&J lands CE mark for surgical stapler that works with Ottava robot (MedTech Dive)
Apr-23-26 11:54AM	Why BSX Stock's Q1 Beat Is A Lagging Indicator (Trefis)
Apr-22-26 01:13PM	Intuitive Surgical Jumps 7% on Earnings Beat and Raised Full-Year Outlook (GuruFocus.com) +7.16%
12:47PM	Intuitive Surgical Q1 results top estimates as robotic surgery demand accelerates (Proactive)
11:28AM	How ISRG Just Secured The U.S. Market (Trefis)
03:04AM	Intuitive Surgical Inc (ISRG) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... (GuruFocus.com)
Apr-21-26 05:14PM	Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies (Barrons.com)
04:38PM	Intuitive Announces First Quarter Earnings (GlobeNewswire)
Apr-09-26 08:11PM	Can 13-15% Procedure Growth in 2026 Sustain ISRG's Premium Valuation? (Quartz)
Apr-08-26 09:31AM	Tired of AI and Oil? Buy the Robot. (Trefis)
Apr-03-26 07:38AM	Restore Robotics cleared to remanufacture 2 more da Vinci Xi instruments (MedTech Dive)
Mar-31-26 06:30AM	Can Boston Scientific Stock Surge 40% From Here? (Trefis)
Mar-24-26 11:03AM	Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems (PR Newswire)
Mar-23-26 01:01AM	ISRG- Not Cheap, But Delivering on Growth Expectations (MoneyShow)
Mar-13-26 02:38PM	Intuitive Surgical Stock Falls After Cybersecurity Breach Hits Internal Systems (GuruFocus.com)
11:47AM	Intuitive Surgical hit by phishing incident (MedTech Dive)
Mar-11-26 09:40AM	Oracle, Nike upgraded: Wall Street's top analyst calls (The Fly)
07:45AM	Here Are Wednesday's Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More (24/7 Wall St.)
05:20AM	Citi upgrades Intuitive Surgical to Buy on recent selloff (TipRanks)
05:10AM	Intuitive Surgical upgraded to Buy from Neutral at Citi (TipRanks)
Mar-10-26 01:39PM	Stryker Introduces SmartHospital Platform to Advance Connected Care (Zacks)
01:11PM	GEHC Wins FDA 510(k) Approval for View, Enhances Radiology Workflows (Zacks)
10:55AM	Here's Why You Should Retain CONMED Stock in Your Portfolio Now (Zacks)
09:34AM	5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside (Zacks)
09:05AM	National Vision Gains 129.5% in a Year: What's Driving the Rally? (Zacks)
08:24AM	Should You Continue to Hold DGX Stock in Your Portfolio? (Zacks)
05:36AM	Intuitive Surgical, Inc. (ISRG) Announces the Completion of its Acquisition of the da Vinci and Ion Distribution Business (Insider Monkey)
02:48AM	SS Innovations raises $18.6M as surgical robot nears US market (MedTech Dive)
Mar-09-26 01:03PM	IDEXX Laboratories Stock Climbs 39.4% in a Year: What's Driving It? (Zacks)
11:53AM	Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment (Zacks)
09:30AM	Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
12:43AM	2 Healthcare Stocks with Exciting Potential and 1 We Avoid (StockStory)
Mar-06-26 05:50PM	Intuitive Surgical, Inc. (ISRG) Stock Moves -1.32%: What You Should Know (Zacks)
11:49AM	Here's Why You Should Add DaVita Stock to Your Portfolio for Now (Zacks)
11:44AM	BDX Secures CE Mark for Revello Stent to Treat Iliac Artery Disease (Zacks)
Mar-05-26 01:00PM	Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates (Zacks)
12:46PM	BD Gains FDA Clearance for Surgiphor 1000mL Surgical Irrigation System (Zacks)
09:33AM	Here's Why You Should Retain INSP Stock in Your Portfolio for Now (Zacks)
09:31AM	RGTI Stock Down Despite Q4 Earnings Top Estimates, Revenues Decline Y/Y (Zacks)
07:43AM	EYE Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
Mar-04-26 12:30PM	Here's Why You Should Retain Clover Stock in Your Portfolio for Now (Zacks)
10:50AM	Stryker Unveils Next-Gen Orthopedic Innovations at AAOS 2026 (Zacks)
09:00AM	This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 08:15AM	Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026? (Zacks)
06:42AM	BOTZ Is A Robotics ETF That Quietly Bets Big on AI Chips (24/7 Wall St.)
Mar-02-26 12:59PM	OGN's VTAMA Cream Shows Sleep Benefits in Pediatric Atopic Dermatitis (Zacks)
12:13PM	5 Stocks Racing Ahead as AI Supercharges Robotics (MarketBeat)
09:00AM	Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock (Zacks)
07:41AM	PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
07:41AM	Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up (Zacks)
07:00AM	Intuitive Expands Investment and Footprint in Europe (GlobeNewswire)
06:27AM	Intuitive expands in Europe with purchase of distributor operations (MedTech Dive)
Mar-01-26 10:37PM	A Look Back at Surgical Equipment & Consumables - Specialty Stocks' Q4 Earnings: Intuitive Surgical (NASDAQ:ISRG) Vs The Rest Of The Pack (StockStory)
10:59AM	Is Becton, Dickinson and Company Stock Outperforming the Dow? (Barchart)
Feb-27-26 12:43PM	Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises (Zacks)
12:38PM	CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash (Zacks)
12:37PM	GEHC & UCSF Form 10-Year Alliance to Advance Imaging & Care Delivery (Zacks)
09:40AM	XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative (Zacks)
07:42AM	TFX Q4 Earnings & Revenues Miss, Margins Down, Stock Up in After-Market (Zacks)
Feb-26-26 11:46AM	GEHC Unveils AI LOGIQ Ultrasound Systems to Boost Imaging & Workflow (Zacks)
11:22AM	Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock Rises (Zacks)
11:21AM	A Decade From Now, You'll Regret Not Buying This 1 Small-Cap Stock (Barchart)
11:21AM	Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now? (Zacks)
Feb-25-26 01:55PM	Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand (Zacks)
01:55PM	FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand (Zacks)
11:57AM	Stryker Launches Synchfix EVT for Flexible Syndesmotic Fixation (Zacks)
11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
09:09AM	Is Intuitive Surgical Stock Underperforming the Dow? (Barchart)

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Executive ChairDr. Gary S. Guthart Ph.D.

CEO & DirectorMr. David J. Rosa

Executive VPMr. Jamie E. Samath

Senior VP of Global Business OperationsMr. Henry L. Charlton

Executive VP and Chief Legal & Compliance OfficerMr. Gary H. Loeb J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rosa David J.	Chief Executive Officer (CEO)	Jul 10 '26	Option Exercise	0.00	1,910	0	247,803	Jul 13 05:54 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 12 '26	Sale	414.13	25	10,353	1,406	Jun 12 06:29 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 11 '26	Sale	412.16	23	9,480	1,431	Jun 12 06:29 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 10 '26	Sale	424.14	23	9,755	1,454	Jun 10 06:01 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 09 '26	Sale	421.13	23	9,686	1,477	Jun 10 06:01 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 08 '26	Sale	420.12	23	9,663	1,500	Jun 10 06:01 PM
LOEB GARY	EVP & Chief Legal and Complian	Jun 10 '26	Sale	424.14	400	169,656	5,720	Jun 10 05:51 PM
GARY LOEB	Officer	Jun 10 '26	Proposed Sale	426.61	400	170,644		Jun 10 04:28 PM
Rosa David J.	Chief Executive Officer (CEO)	Jun 10 '26	Option Exercise	0.00	1,358	0	246,567	Jun 10 01:24 PM
MARK BROSIUS	Officer	Jun 08 '26	Proposed Sale	422.06	665	280,670		Jun 08 04:38 PM
AMAL JOHNSON	Director	Jun 03 '26	Proposed Sale	402.30	12,472	5,017,486		Jun 03 04:27 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Jun 01 '26	Option Exercise	77.00	5,625	433,119	12,088	Jun 02 10:08 AM
Jeddi Iman	SVP & GM da Vinci Platforms &	Jun 01 '26	Sale	420.55	5,625	2,365,594	6,463	Jun 02 10:08 AM
IMAN JEDDI	Officer	Jun 01 '26	Proposed Sale	420.55	5,625	2,365,594		Jun 01 04:06 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 21 '26	Sale	446.04	18	8,029	1,541	May 22 08:09 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 22 '26	Sale	439.80	18	7,916	1,523	May 22 08:09 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 19 '26	Sale	440.70	18	7,933	1,577	May 20 06:02 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 20 '26	Sale	440.38	18	7,927	1,559	May 20 06:02 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 18 '26	Sale	422.47	18	7,604	1,595	May 20 06:02 PM
LOEB GARY	EVP & Chief Legal and Complian	May 11 '26	Sale	446.95	400	178,780	6,120	May 11 07:11 PM
GARY LOEB	Officer	May 11 '26	Proposed Sale	450.06	400	180,024		May 11 04:35 PM
Reed Monica P	Director	Apr 30 '26	Option Exercise	0.00	531	0	2,876	Apr 30 09:13 PM
NACHTSHEIM JAMI K	Director	Apr 30 '26	Option Exercise	0.00	531	0	6,902	Apr 30 09:07 PM
Leonard Keith R	Director	Apr 30 '26	Option Exercise	0.00	531	0	901	Apr 30 09:02 PM
Ladd Amy L	Director	Apr 30 '26	Option Exercise	0.00	531	0	651	Apr 30 08:56 PM
Kolli Sreelakshmi	Director	Apr 30 '26	Option Exercise	0.00	531	0	1,510	Apr 30 08:51 PM
Johnson Amal M	Director	Apr 30 '26	Option Exercise	0.00	531	0	13,545	Apr 30 08:44 PM
CHEW LEWIS	Director	Apr 30 '26	Option Exercise	0.00	531	0	1,314	Apr 30 08:36 PM
Beery Joseph C	Director	Apr 30 '26	Option Exercise	0.00	531	0	3,641	Apr 30 08:21 PM
BARRATT CRAIG H	Director	Apr 30 '26	Option Exercise	0.00	750	0	27,948	Apr 30 08:12 PM
Ladd Amy L	Director	Apr 28 '26	Sale	473.46	500	236,730	239	Apr 29 05:38 PM
Ladd Amy L	Director	Apr 29 '26	Sale	463.50	119	55,156	120	Apr 29 05:38 PM
AMY LADD	Director	Apr 28 '26	Proposed Sale	470.99	619	291,543		Apr 28 04:31 PM
MCADAMS FAMILY REVOCABLE LIVIN	Former Officer	Apr 27 '26	Proposed Sale	470.91	30,417	14,323,761		Apr 27 04:37 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 10 '26	Option Exercise	229.39	105	24,086	105	Mar 11 01:46 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 10 '26	Sale	493.95	105	51,865	0	Mar 11 01:46 PM
MYRIAM CURET MCADAMS	Officer	Mar 10 '26	Proposed Sale	493.95	105	51,865		Mar 10 04:47 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 06 '26	Sale	490.19	648	317,643	2,258	Mar 10 02:24 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 09 '26	Sale	485.01	645	312,831	1,613	Mar 10 02:24 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 04 '26	Sale	498.68	2,362	1,177,883	3,554	Mar 05 06:38 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 05 '26	Sale	495.20	648	320,890	2,906	Mar 05 06:38 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 03 '26	Sale	488.10	648	316,289	5,916	Mar 05 06:38 PM
MARK BROSIUS	Officer	Mar 05 '26	Proposed Sale	501.18	1,714	859,023		Mar 05 04:43 PM
BRIAN MILLER	Officer	Mar 04 '26	Proposed Sale	497.42	8,368	4,162,411		Mar 04 04:43 PM
Widman Fredrik	VP Corporate Controller	Feb 28 '26	Option Exercise	0.00	468	0	1,377	Mar 03 06:17 PM
Widman Fredrik	VP Corporate Controller	Feb 27 '26	Sale	499.71	249	124,428	909	Mar 03 06:17 PM
Widman Fredrik	VP Corporate Controller	Mar 03 '26	Sale	487.18	118	57,487	1,026	Mar 03 06:17 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 02 '26	Option Exercise	208.90	125	26,112	5,262	Mar 03 05:34 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 03 '26	Sale	487.18	4,728	2,303,387	409	Mar 03 05:34 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 02 '26	Sale	492.59	125	61,574	5,137	Mar 03 05:34 PM
MARK BROSIUS	Officer	Mar 03 '26	Proposed Sale	496.25	3,327	1,651,024		Mar 03 04:32 PM
FREDRIK WIDMAN	Officer	Mar 03 '26	Proposed Sale	487.18	118	57,487		Mar 03 04:29 PM
MYRIAM CURET MCADAMS	Officer	Mar 03 '26	Proposed Sale	487.18	4,728	2,303,387		Mar 03 04:17 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Feb 28 '26	Option Exercise	0.00	9,004	0	10,618	Mar 03 12:53 PM
GUTHART GARY S	Director	Feb 28 '26	Option Exercise	0.00	28,840	0	36,848	Mar 03 12:25 PM
Samath Jamie	EVP & CFO & Enterprise Technol	Feb 28 '26	Option Exercise	0.00	11,525	0	20,709	Mar 02 07:41 PM
LOEB GARY	EVP & Chief Legal and Complian	Feb 28 '26	Option Exercise	0.00	3,148	0	8,082	Mar 02 06:40 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Feb 28 '26	Option Exercise	0.00	11,525	0	16,410	Mar 02 05:17 PM
Rosa David J.	Chief Executive Officer (CEO)	Feb 28 '26	Option Exercise	0.00	24,918	0	249,698	Mar 02 05:02 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 28 '26	Option Exercise	0.00	9,255	0	10,719	Mar 02 04:48 PM
MYRIAM CURET MCADAMS	Officer	Mar 02 '26	Proposed Sale	492.59	125	61,574		Mar 02 04:09 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 28 '26	Option Exercise	0.00	9,380	0	9,292	Mar 02 03:41 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 27 '26	Sale	499.71	2,345	1,171,820	409	Mar 02 03:41 PM
WADORS PATRICIA L	SVP Chief Human Resources Offi	Feb 26 '26	Option Exercise	0.00	458	0	458	Feb 27 06:43 PM
WADORS PATRICIA L	SVP Chief Human Resources Offi	Feb 27 '26	Sale	499.71	220	109,936	0	Feb 27 06:43 PM
FREDRIK WIDMAN	Officer	Feb 27 '26	Proposed Sale	499.71	249	124,428		Feb 27 04:24 PM
MYRIAM CURET MCADAMS	Officer	Feb 27 '26	Proposed Sale	499.71	2,345	1,171,820		Feb 27 04:11 PM
PATRICIA WADORS	Officer	Feb 27 '26	Proposed Sale	499.71	220	109,936		Feb 27 04:09 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Feb 26 '26	Option Exercise	0.00	2,309	0	2,263	Feb 27 03:04 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Feb 26 '26	Option Exercise	0.00	2,747	0	5,679	Feb 27 02:53 PM
Samath Jamie	EVP & CFO & Enterprise Technol	Feb 26 '26	Option Exercise	0.00	3,396	0	10,295	Feb 27 02:45 PM
LOEB GARY	EVP & Chief Legal and Complian	Feb 26 '26	Option Exercise	0.00	2,442	0	5,389	Feb 27 02:36 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 26 '26	Option Exercise	0.00	4,654	0	3,549	Feb 27 02:00 PM
Widman Fredrik	VP Corporate Controller	Feb 26 '26	Option Exercise	0.00	989	0	1,346	Feb 27 01:52 PM
Rosa David J.	Chief Executive Officer (CEO)	Feb 26 '26	Option Exercise	0.00	6,105	0	233,783	Feb 27 01:42 PM
GUTHART GARY S	Director	Feb 26 '26	Option Exercise	0.00	8,393	0	10,954	Feb 27 01:32 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 26 '26	Option Exercise	0.00	2,595	0	2,382	Feb 27 01:19 PM
BRIAN MILLER	Officer	Feb 18 '26	Proposed Sale	493.35	647	319,197		Feb 18 04:37 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 10 '26	Option Exercise	25.54	943	24,086	1,247	Feb 11 05:37 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 11 '26	Sale	494.96	421	208,378	409	Feb 11 05:37 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 10 '26	Sale	494.65	105	51,938	830	Feb 11 05:37 PM
Widman Fredrik	VP Corporate Controller	Feb 10 '26	Option Exercise	0.00	567	0	1,095	Feb 11 05:17 PM
Widman Fredrik	VP Corporate Controller	Feb 11 '26	Sale	494.96	133	65,830	660	Feb 11 05:17 PM
FREDRIK WIDMAN	Officer	Feb 11 '26	Proposed Sale	494.96	133	65,830		Feb 11 04:05 PM
MYRIAM CURET MCADAMS	Officer	Feb 11 '26	Proposed Sale	494.96	421	208,378		Feb 11 04:02 PM
Rosa David J.	Chief Executive Officer (CEO)	Feb 10 '26	Option Exercise	0.00	1,436	0	230,294	Feb 10 04:28 PM
GUTHART GARY S	Director	Feb 10 '26	Option Exercise	0.00	2,633	0	6,327	Feb 10 04:18 PM
MYRIAM CURET MCADAMS	Officer	Feb 10 '26	Proposed Sale	494.65	105	51,938		Feb 10 04:04 PM
LOEB GARY	EVP & Chief Legal and Complian	Feb 10 '26	Option Exercise	0.00	315	0	3,876	Feb 10 03:51 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Feb 10 '26	Option Exercise	0.00	838	0	894	Feb 10 03:26 PM
Samath Jamie	EVP & CFO & Enterprise Technol	Feb 10 '26	Option Exercise	0.00	1,077	0	8,295	Feb 10 03:16 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Feb 10 '26	Option Exercise	0.00	1,077	0	4,189	Feb 10 02:16 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 10 '26	Option Exercise	0.00	838	0	1,025	Feb 10 01:54 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 29 '26	Option Exercise	208.90	126	26,321	126	Jan 30 09:16 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 29 '26	Sale	520.02	126	65,523	0	Jan 30 09:16 PM
MYRIAM CURET MCADAMS	Officer	Jan 29 '26	Proposed Sale	520.02	126	65,523		Jan 29 04:01 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 27 '26	Option Exercise	218.25	230	50,198	125	Jan 28 04:34 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 27 '26	Sale	532.61	230	122,500	0	Jan 28 04:34 PM
GUTHART GARY S	Director	Jan 27 '26	Option Exercise	174.26	25,500	4,443,546	28,194	Jan 28 04:20 PM
GUTHART GARY S	Director	Jan 27 '26	Sale	530.10	24,500	12,987,403	3,694	Jan 28 04:20 PM

CAMP CAMP4 Therapeutics Corp daily Stock Chart

Peers: KPTI OABI CNTX HUMA RNA TENX TNXP UNCY WHWK MIST

| Held by: VTI IWM VXF IWO VTWO IWC GSSC VTWG RSSL OMFS

Index	RUT
Market Cap	211.85M
Enterprise Value	114.03M
Income	-86.30M
Sales	3.93M
Book/sh	0.60
Cash/sh	1.92
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	48
IPO	Oct 11, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	53.91
P/B	6.86
P/C	2.12
P/FCF	-
EV/EBITDA	-
EV/Sales	29.02
Quick Ratio	6.15
Current Ratio	6.15
Debt/Eq	0.07
LT Debt/Eq	0.06
Option/Short	No / Yes

EPS (ttm)	-2.27
EPS next Y	-0.73
EPS next Q	-0.21
EPS this Y	69.33%
EPS next Y	9.67%
EPS next 5Y	33.58%
EPS past 3/5Y	-5.31% -
Sales past 3/5Y	- -
EPS Y/Y TTM	12.32%
Sales Y/Y TTM	160.53%
EPS Q/Q	48.70%
Sales Q/Q	50.82%
Earnings	May 07 AMC
EPS/Sales Surpr.	-52.38% 15.86%

Insider Own	48.93%
Insider Trans	0.00%
Inst Own	55.84%
Inst Trans	4.17%
ROA	-102.60%
ROE	-209.28%
ROIC	-264.40%
Gross Margin	55.82%
Oper. Margin	-1322.62%
Profit Margin	-2193.72%
SMA20	-3.64%
SMA50	-4.09%
SMA200	-7.72%
Trades

Shs Outstand	51.93M
Shs Float	26.52M
Short Float	4.94%
Short Ratio	7.46
Short Interest	1.31M
52W High	7.75 -47.35%
52W Low	1.32 209.09%
Volatility	9.14% 9.91%
ATR (14)	0.40
RSI (14)	47.08
Beta	0.21
Rel Volume	0.02
Avg Volume	175.89K
Volume	203

Perf Week	-9.33%
Perf Month	-1.45%
Perf Quarter	-9.13%
Perf Half Y	-29.41%
Perf YTD	-33.44%
Perf Year	156.60%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	8.36
Prev Close	3.71
Price	4.08
Change	9.97%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-26	Upgrade	JP Morgan	Neutral → Overweight	$9
Jun-10-26	Initiated	Chardan Capital Markets	Buy	$6.50
Apr-14-26	Initiated	Rodman & Renshaw	Buy	$7
Oct-02-25	Initiated	Cantor Fitzgerald	Overweight	$7
Sep-16-25	Downgrade	JP Morgan	Overweight → Neutral
May-27-25	Initiated	Wedbush	Outperform	$8
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	Piper Sandler	Overweight	$18
Nov-05-24	Initiated	JP Morgan	Overweight	$23

Jul-17-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +9.97%
Jun-19-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-21-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-14-26 07:00AM	CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder (GlobeNewswire)
May-07-26 04:05PM	CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights (GlobeNewswire) +6.90%
08:00AM	Loading…
Apr-28-26 08:00AM	CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation (GlobeNewswire)
Apr-17-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-24-26 07:00AM	CAMP4 Appoints Michael MacLean to its Board of Directors (GlobeNewswire)
Mar-06-26 04:05PM	CAMP4 to Participate in Upcoming Investor Conferences (GlobeNewswire) -8.50% +49.40%
Mar-05-26 04:05PM	CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights (GlobeNewswire) +12.50%
Feb-20-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-16-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -21.00%
Jan-13-26 12:00PM	CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why (Zacks)
Jan-06-26 08:00AM	CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-02-26 03:22PM	Getty Images, Torm, and More Stocks See Action From Activist Investors (Barrons.com)
06:01AM	Loading…
Dec-19-25 06:01AM	Novo files for CagriSema approval; Merck and Pfizers trial win (BioPharma Dive)
Dec-18-25 07:10AM	CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock (GlobeNewswire) -12.90%
07:00AM	CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries (GlobeNewswire)
Dec-12-25 04:05PM	CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.99%
Nov-14-25 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-06-25 04:05PM	CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) +6.97%
Oct-14-25 02:09PM	3 Healthcare Companies Insiders Are Buying (MarketBeat) -6.63%
Oct-01-25 08:00AM	CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 (GlobeNewswire)
Sep-25-25 12:00PM	CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know (Zacks) +7.53%
Sep-17-25 09:40AM	Apple initiated, Hershey upgraded: Wall Streets top analyst calls (TipRanks) -6.50%
Sep-16-25 09:35AM	Apple initiated, Hershey upgraded: Wall Street's top analyst calls (The Fly)
Sep-10-25 07:00AM	CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders (GlobeNewswire) +40.20%
Aug-14-25 04:05PM	CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) +6.16% +7.74%
Jun-30-25 08:00AM	Sequans Appoints Jason W. Cohenour to Board of Directors (Newsfile)
May-16-25 06:00AM	CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire) +9.52%
04:05PM	Loading…
May-13-25 04:05PM	CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) -7.92%
Apr-28-25 04:30PM	CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire) -10.00% -5.15%
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Mar-27-25 04:05PM	CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -10.16%
Mar-18-25 08:00AM	CAMP4 Appoints Multiple Industry Veterans to its Board of Directors (GlobeNewswire)
Mar-04-25 05:24AM	CAMP4 Therapeutics Corporation (CAMP): Among Penny Stocks with Insider Buying in 2025 (Insider Monkey) -5.27%
Feb-06-25 08:00AM	CAMP4 to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.95%
Jan-13-25 08:00AM	CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-07-25 04:05PM	CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones (GlobeNewswire)
Dec-10-24 08:00AM	CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors (GlobeNewswire) -8.08%
Dec-02-24 08:00AM	CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +5.85%
Nov-21-24 04:05PM	CAMP4 Reports Third Quarter 2024 Financial Results (GlobeNewswire) +8.44% -6.40%
Oct-10-24 07:07PM	CAMP4 Announces Pricing of Initial Public Offering (GlobeNewswire)

CAMP4 Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a class of RNA-targeting therapeutics for upregulating gene expression and restoration of healthy protein levels to treat a broad range of genetic diseases. Its lead product candidate is CMP-002. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

CEOMr. Joshua Mandel-Brehm

Founder & Independent DirectorDr. Richard A. Young Ph.D.

Chief Financial OfficerMs. Kelly Gold

M.D.Dr. Yuri Maricich M.B.A.

Founder & Chairman of Scientific Advisory BoardDr. Leonard I. Zon M.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
5AM Partners VI, LLC	10% Owner	Sep 11 '25	Buy	1.53	2,941,176	4,499,999	2,941,176	Sep 15 08:12 PM
Polaris Management Co. VII, L.	10% Owner	Sep 11 '25	Buy	1.53	1,307,189	1,999,999	2,825,500	Sep 11 04:59 PM
Nashat Amir	Director	Sep 11 '25	Buy	1.53	1,307,189	1,999,999	2,825,500	Sep 11 04:48 PM
Maricich Yuri	Chief Medical Officer	Sep 11 '25	Buy	1.65	6,060	9,999	6,060	Sep 11 04:25 PM
Gold Kelly	Chief Financial Officer	Sep 11 '25	Buy	1.65	6,060	9,999	67,877	Sep 11 04:24 PM
Mandel-Brehm Josh	Chief Executive Officer	Sep 11 '25	Buy	1.65	6,060	9,999	278,417	Sep 11 04:23 PM
Young Richard A	Director	Sep 11 '25	Buy	1.65	15,151	24,999	170,010	Sep 11 04:22 PM

ISRG

Intuitive Surgical Inc

CAMP

CAMP4 Therapeutics Corp

Upgrade your Finviz experience